Results 251 to 260 of about 10,256,810 (359)

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Clinical pharmacists and nurses in the management of oral mucositis in head and neck cancer patients during antineoplastic therapy: A scoping review. [PDF]

SAGE Open Med
Kaisha P, Li X, Tang Y, Zheng Y.
europepmc   +1 more source

Physician experiences with clinical pharmacists in primary care teams.

Journal of the American Pharmacists Association, 2017
Gerardo Moreno, Sarah Lonowski, Jeffrey Fu, Janet S. Chon, Natalie Whitmire, C. Vásquez, S. Skootsky, D. Bell, Richard Maranon, C. Mangione   +9 more
semanticscholar   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Medication stewardship by clinical pharmacists in acute ischemic stroke care: a retrospective analysis of drug-related problem reduction and cost-saving outcomes. [PDF]

Front Pharmacol
Chen X, Hu X, Su Q, Zhu L, Tang Z, Tang C, Yang S.   +6 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Benchmarking ChatGPT-3.5 and OpenAI o3 Against Clinical Pharmacists: Preliminary Insights into Clinical Accuracy, Sensitivity, and Specificity in Pharmacy MCQs. [PDF]

Healthcare (Basel)
Alsaudi EM, Shilbayeh SA, Abu-Farha RK.
europepmc   +1 more source

Quit bellyaching: the men and indigestion pilot study: executive summary [PDF]

, 2004
Hemingway, Ann, Taylor, G., Young, Natasha   +2 more
core  

Clinical pharmacists in primary care: a safe solution to the workforce crisis?

Journal of the Royal Society of Medicine, 2018
Daoroong Komwong, G. Greenfield, H. Zaman, A. Majeed, B. Hayhoe   +4 more
semanticscholar   +1 more source